Table 1: General characteristics of normal glucose participants and newly diagnosed T2DM patients.

VariablesNDMT2DM value

Gender (male/)31/58 (53.4%)38/73 (52.1%)0.874
Age (years)39.43 ± 12.0841.03 ± 9.740.404
BMI (kg/m2)26.80 ± 4.2627.66 ± 3.390.204
WHR0.91 ± 0.070.93 ± 0.060.100
Betatrophin (pg/mL)407.41 (172.76–528.32)747.12 (544.26–1074.96)<0.001
Fasting glucose (mM)5.51 ± 0.6312.11 ± 3.89<0.001
Fast insulin (mIU/L)10.42 ± 5.8315.10 ± 8.18<0.001
C peptide (g/L)1.65 ± 0.762.58 ± 2.970.021
HOMA-IR2.88 ± 1.987.90 ± 3.89<0.001
HOMA-%92.45 ± 46.8344.77 ± 37.37<0.001
QUICKI0.34 ± 0.040.29 ± 0.02<0.001
TC (mM)4.89 ± 1.235.47 ± 1.150.007
TG (mM)1.29 (0.71–2.06)1.66 (1.09–2.35)0.213
LDL-C (mM)3.32 ± 0.923.42 ± 0.950.559
HDL-C (mM)1.50 ± 0.471.01 ± 0.37<0.001
Uric acid (mol/L)378.32 ± 110.26335.40 ± 93.810.018
ALT (IU/L)21 (14–37.8)21 (14.5–31)0.308
AST (IU/L)24.28 ± 9.1820.99 ± 12.480.096

BMI: body mass index; WHR: waist-to-hip ratio; FINS: fasting blood insulin; FBG: fasting blood glucose; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-%: homeostasis model assessment of cell function; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; QUICKI: Quantitative Insulin Sensitivity Check Index; ALT: alanine aminotransferase; AST: aspartate aminotransferase.
.